Endometrial Carcinoma
Oncology·MeSH: Endometrial Neoplasms
Prevalence
58.0 / 100K
Incidence
28.0 / 100K/yr
1 drug in development·1 company·9 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Lenvima | Merck & Co., Inc. (MRK) |
Frequently asked questions
How many drugs are in development for Endometrial Carcinoma?
BioSniper tracks 1 drug in development for Endometrial Carcinoma across 1 company.
How many clinical trials target Endometrial Carcinoma?
There are 9 clinical trials targeting Endometrial Carcinoma tracked by BioSniper.
What is the prevalence of Endometrial Carcinoma?
The estimated prevalence of Endometrial Carcinoma is approximately 58.0 per 100,000 population.
Deep-dive into Endometrial Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis